***************
Pharmacology & Toxicology Poster Session






Abstract

Introduction

Materials & Methods

Results

Discussion & Conclusion

References




Discussion
Board

INABIS '98 Home Page Your Session Symposia & Poster Sessions Plenary Sessions Exhibitors' Foyer Personal Itinerary New Search

Drug Utilization Study in Bronchial Asthma Treatment


Contact Person: Miriam Cires (cdf@infomed.sld.cu)


Results

PATIENTS FEATURES

Patients

n

%

GENDER

Female

407

54.3

Male

342

45.7

AGE GROUPS

1-4

48

6.4

5-14

157

21

15-29

189

25.2

Over 30

355

47.4

PATIENTS CLASSIFICATION ATTENDING DEGREE OF DISEASE

n

%

Mild

224

30

Moderate

131

17.4

Severe

142

19

No classified

201

26.8

No records

51

6.8

Definitions of disease degrees

Mild: < 6 crisis per year

Moderate: 6 to 9 crises per year

Severe: 10 or more crises per year

Not classified: not enclosed in previous categories

No record: no clinical record was found.

EXTENT OF DISEASE CONTROL

Asthmatic crises

Patients

N %

Yes

557 74

No

192 96

Wards admission

Yes

84 11

No

665 89

INFORMATION SOURCES ABOUT TREATMENT

N %
PRESCRIBED in CLINICAL RECORD
Yes 299 39.9
No 399 53.2
No clinical record 51 6.8
REFERRED by PATIENT
Yes 646 86.3
No 103 13.7

PHARMACOLOGICAL GROUPS USED TO TREAT SYMPTOMS

Prescribed in Clinical Record Referred by Patients

N

%

n

%

BRONCHODILATORS
  • b 2 agonists
150 45.6 483 54.7
  • Xantines
110 31.6 195 22.1

Antihistamines H1

17 4.9 40 4.5

Sodium cromoglicate

2 0.6 6 0.6

Corticoids

9 2.6 54 6.1

Fixed Drug Combinations

45 13 75 8.5

Other

6 1.7 30 3.4

Results by number of drugs (%)

PHARMACOLOGICAL GROUPS for PROPHYLAXIS

Prescribed in Clinical Record Referred by Patients
n % N %
Bronchodilators
b 2 agonists 20 14.5 40 11.3
Xantines 9 6.7 20 5.6
Antihistamines H1 57 41.6 178 50.1
Sodium Cromoglicate 29 21.2 58 16.3
Corticoids * 12 8.7 26 7.3
Fixed drugs Combinations 4 3.0 16 4.5
Other 6 4.3 17 5.0
Results by number of drugs (%)

* In Cuba there are not inhaled corticoids registered.

INHALED b 2 AGONIST FOR SYMPTOMATIC TREATMENT ACCORDING WITH DISEASE DEGREE

#Times inhaled

MILD MODERATE

SEVERE

NO Classified

No clinical record

TOTAL

n

%

n

%

n

%

n

%

n

%

n

%

1

24

57.1

6

14.3

1

2.4

11

26.2

42

100

2 8

72

28.3

57

22.4

58

22.8

52

20.5

15

6

254

100

More than 8

5

29.4

1

5.9

7

41.2

4

23.5

17

100

As needed

27

18.4

21

14.3

49

33.3

36

24.5

14

9.5

147

100

Results by number of patients (%)

Back to the top.


<= Materials & Methods RESULTS Discussion & Conclussions =>

| Discussion Board | Next Page | Your Poster Session |
Cires, M; Zapata, A; Sinclair, G; Portuondo, C; (1998). Drug Utilization Study in Bronchial Asthma Treatment. Presented at INABIS '98 - 5th Internet World Congress on Biomedical Sciences at McMaster University, Canada, Dec 7-16th. Available at URL http://www.mcmaster.ca/inabis98/pharmtox/cires0750/index.html
© 1998 Author(s) Hold Copyright